Accurate dose prediction for clinical trials is essential to ensure patient safety and trial success.

This new whitepaper from the Jackson Laboratory discusses evidence-based selection of starting doses in first-in-human clinical trials through the utilisation of humanised mouse models.

In this whitepaper you will learn about:

  • The significance of selecting appropriate starting doses in clinical trials.
  • Utilising humanised mouse models to mimic human responses.
  • Integration of preclinical data and physiological parameters for dose prediction.
  • Advantages of refining dosing strategies, minimising risks, and improving trial outcomes.
  • Enhancing understanding of drug behaviour, toxicity, and efficacy in humans.
  • The potential to revolutionise drug development by optimising dose selection.

Download the whitepaper for free.